BioCentury
ARTICLE | Company News

Biocoll, Osteopharm Ltd. deal

January 27, 1997 8:00 AM UTC

BLM completed its acquisition of Osteopharm, a developer of osteoporosis compounds, by issuing 9.2 million shares of BLM to Osteopharm's existing shareholders. Concurrently, BLM raised C$10 million in...